The F.D.A. “fumbled by allowing A.I. developers to keep their secret sauce under wraps and failing to require careful studies to assess any meaningful benefits.
“You have to have really compelling, great data to change medical practice & to exude confidence that this is the way to go,” said Dr. Topol, executive vice president of Scripps Research in San Diego. Instead, he added, the F.D.A. has allowed “shortcuts.””
https://www.nytimes.com/2023/10/30/health/doctors-ai-technology-health-care.html
“You have to have really compelling, great data to change medical practice & to exude confidence that this is the way to go,” said Dr. Topol, executive vice president of Scripps Research in San Diego. Instead, he added, the F.D.A. has allowed “shortcuts.””
https://www.nytimes.com/2023/10/30/health/doctors-ai-technology-health-care.html